ChartRow logo
ChartRow
Stocks and ETFs

financial statements

The full income statement, balance sheet, and cash-flow statement for Eastman Chemical Company (EMN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

See the live EMN chart & snapshot →

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
8.75B
YoY-6.7%
9.38B
YoY+1.9%
9.21B
YoY-12.9%
10.6B
YoY+1.0%
10.5B
YoY+23.6%
1.84B
YoY-19.5%
2.29B
YoY+11.1%
2.06B
YoY-3.6%
2.14B
YoY-14.5%
2.50B
YoY+26.6%
Research & development
255M
YoY+2.0%
250M
YoY+4.6%
239M
YoY-9.5%
264M
YoY+3.9%
254M
YoY+12.4%
Selling, general & administrative
658M
YoY-10.6%
736M
YoY+1.2%
727M
YoY+0.1%
726M
YoY-8.7%
795M
YoY+21.6%
Amortization of intangibles
79.0M
YoY-3.7%
82.0M
YoY-4.7%
86.0M
YoY-1.1%
87.0M
YoY-19.4%
108M
YoY-15.6%
Net interest income
-208M
YoY-4.0%
-200M
YoY+7.0%
-215M
YoY-18.1%
-182M
YoY+8.1%
-198M
YoY+5.7%
Other non-operating income
-74.0M
YoY-105.6%
-36.0M
YoY+2.7%
-37.0M
YoY-1333.3%
3.00M
YoY-72.7%
11.0M
YoY+257.1%
Pre-tax income
568M
YoY-47.3%
1.08B
YoY-0.8%
1.09B
YoY+11.3%
977M
YoY-9.7%
1.08B
YoY+104.2%
Income tax
93.0M
YoY-45.3%
170M
YoY-11.0%
191M
YoY+5.5%
181M
YoY-15.8%
215M
YoY+424.4%
474M
YoY-47.6%
905M
YoY+1.2%
894M
YoY+12.7%
793M
YoY-7.5%
857M
YoY+79.3%
$4.10
YoY-46.5%
$7.67
YoY+2.4%
$7.49
YoY+18.0%
$6.35
YoY+1.6%
$6.25
YoY+78.6%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
3.65B
YoY-11.1%
4.10B
YoY+17.8%
3.48B
YoY-7.9%
3.78B
YoY-18.7%
4.65B
YoY+31.2%
14.9B
YoY-2.3%
15.2B
YoY+4.0%
14.6B
YoY-0.2%
14.7B
YoY-5.5%
15.5B
YoY-3.5%
2.65B
YoY-2.1%
2.71B
YoY+5.1%
2.58B
YoY-20.8%
3.25B
YoY+9.4%
2.97B
YoY+45.8%
8.82B
YoY-5.8%
9.36B
YoY+2.8%
9.10B
YoY-3.5%
9.43B
YoY-3.1%
9.73B
YoY-2.4%
5.96B
YoY+3.1%
5.78B
YoY+5.9%
5.46B
YoY+5.9%
5.15B
YoY-9.7%
5.70B
YoY-5.3%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
970M
YoY-24.6%
1.29B
YoY-6.3%
1.37B
YoY+40.9%
975M
YoY-39.8%
1.62B
YoY+11.3%
-462M
YoY+13.5%
-534M
YoY-23.6%
-432M
YoY-210.2%
392M
YoY+1451.7%
-29.0M
YoY+92.6%
-797M
YoY-75.6%
-454M
YoY+48.9%
-888M
YoY+32.8%
-1.32B
YoY+21.8%
-1.69B
YoY-140.1%
FX effect on cash
18.0M
YoY+280.0%
-10.0M
YoY-1100.0%
1.00M
YoY+108.3%
-12.0M
YoY-140.0%
-5.00M
YoY-266.7%
Net change in cash
-271M
YoY-193.8%
289M
YoY+425.5%
55.0M
YoY+61.8%
34.0M
YoY+132.4%
-105M
YoY-129.2%
Interest paid
215M
YoY+5.9%
203M
YoY-5.1%
214M
YoY+19.6%
179M
YoY+5.3%
170M
YoY-11.0%
Income taxes paid
159M
YoY+43.2%
111M
YoY-29.7%
158M
YoY+102.6%
78.0M
YoY-36.1%
122M
YoY-31.8%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
7.28B
YoY-30.8%
10.5B
YoY-0.2%
10.5B
YoY+8.9%
9.67B
YoY-38.0%
15.6B
YoY+14.5%
P/E
15.4×
YoY+32.2%
11.6×
YoY-36.2%
18.2×
YoY+118.0%
8.4×
YoY-54.1%
18.2×
YoY-36.2%
P/S
0.8×
YoY-25.8%
1.1×
YoY-1.3%
1.1×
YoY+26.7%
0.9×
YoY-39.8%
1.5×
YoY-7.4%
P/B
1.2×
YoY-32.9%
1.8×
YoY-8.5%
2.0×
YoY+9.6%
1.8×
YoY-33.6%
2.7×
YoY+20.9%
P/FCF
17.2×
YoY+12.4%
15.3×
YoY-24.4%
20.2×
YoY-38.0%
32.6×
YoY+122.3%
14.7×
YoY+15.3%
Earnings yield
6.5%
YoY-24.4%
8.6%
YoY+56.6%
5.5%
YoY-54.1%
12.0%
YoY+117.9%
5.5%
YoY+56.6%
FCF yield
5.8%
YoY-11.0%
6.5%
YoY+32.2%
4.9%
YoY+61.2%
3.1%
YoY-55.0%
6.8%
YoY-13.3%
Dividend yield
5.2%
YoY+46.1%
3.6%
YoY+0.8%
3.5%
YoY-6.1%
3.8%
YoY+61.1%
2.3%
YoY-12.1%
Source filing10-K10-K10-K10-K10-K

About this data

Source: EMN's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all EMN filings on SEC EDGAR → Not investment advice.